{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T19:12:37Z","timestamp":1793646757299,"version":"4.5.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.josat.2023.209164","type":"journal-article","created":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T02:11:33Z","timestamp":1695003093000},"page":"209164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["COVID-19-related flexibility in methadone take-home doses associated with decreased attrition: Report from an opioid treatment program in central Pennsylvania"],"prefix":"10.1016","volume":"155","author":[{"given":"Sarah S.","family":"Kawasaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Zimmerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra E.","family":"Zgierska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.josat.2023.209164_bb0005","doi-asserted-by":"crossref","first-page":"108552","DOI":"10.1016\/j.jsat.2021.108552","article-title":"Changes in methadone take-home dosing before and after COVID-19","volume":"133","author":"Amram","year":"2022","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1\u20132","key":"10.1016\/j.josat.2023.209164_bb0010","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.drugalcdep.2012.12.013","article-title":"Probability and predictors of treatment-seeking for prescription opioid use disorders: A national study","volume":"131","author":"Blanco","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2023.209164_bb0015","doi-asserted-by":"crossref","first-page":"108449","DOI":"10.1016\/j.jsat.2021.108449","article-title":"Changes in methadone program practices and fatal methadone overdose rates in Connecticut during COVID-19","volume":"131","author":"Brothers","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2023.209164_bb0020","author":"Center for Disease Control, National Center for Health Statistics"},{"issue":"3","key":"10.1016\/j.josat.2023.209164_bb0025","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1360-0443.2007.02090.x","article-title":"Exposure to opioid maintenance treatment reduces long-term mortality","volume":"103","author":"Gibson","year":"2008","journal-title":"Addiction"},{"issue":"9","key":"10.1016\/j.josat.2023.209164_bb0030","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1001\/jama.2022.1271","article-title":"Association between increased dispensing of opioid agonist therapy take-home doses and opioid overdose and treatment interruption and discontinuation","volume":"327","author":"Gomes","year":"2022","journal-title":"Jama"},{"issue":"3","key":"10.1016\/j.josat.2023.209164_bb0035","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1600-0447.1990.tb03057.x","article-title":"Mortality in heroin addiction: Impact of methadone treatment","volume":"82","author":"Gr\u00f6nbladh","year":"1990","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1016\/j.josat.2023.209164_bb0040","doi-asserted-by":"crossref","first-page":"108801","DOI":"10.1016\/j.jsat.2022.108801","article-title":"Treatment retention, return to use, and recovery support following COVID-19 relaxation of methadone take-home dosing in two rural opioid treatment programs: A mixed methods analysis","volume":"141","author":"Hoffman","year":"2022","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2023.209164_bb0045","doi-asserted-by":"crossref","first-page":"108008","DOI":"10.1016\/j.jsat.2020.108008","article-title":"Characterizing variability in state-level regulations governing opioid treatment programs","volume":"115","author":"Jackson","year":"2020","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"3","key":"10.1016\/j.josat.2023.209164_bb0050","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/08897077.2021.1975344","article-title":"Research priorities for expanding access to methadone treatment for opioid use disorder in the United States: A National Institute on Drug Abuse Clinical Trials Network Task Force report","volume":"42","author":"Joudrey","year":"2021","journal-title":"Substance Abuse"},{"key":"10.1016\/j.josat.2023.209164_bb0055","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jsat.2019.08.016","article-title":"Multi-model implementation of evidence-based care in the treatment of opioid use disorder in Pennsylvania","volume":"106","author":"Kawasaki","year":"2019","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"2\u20133","key":"10.1016\/j.josat.2023.209164_bb0060","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.drugalcdep.2011.01.008","article-title":"Predictors of methadone treatment retention from a multi-site study: A survival analysis","volume":"117","author":"Kelly","year":"2011","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2023.209164_bb0065","doi-asserted-by":"crossref","first-page":"103644","DOI":"10.1016\/j.drugpo.2022.103644","article-title":"Impact of the COVID-19 pandemic on the provision of take-home doses of opioid agonist therapy in Ontario, Canada: A population-based time-series analysis","volume":"103","author":"Kitchen","year":"2022","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.josat.2023.209164_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2015.12.021","article-title":"Opioid substitution therapy: Lowering the treatment thresholds","volume":"161","author":"Kourounis","year":"2016","journal-title":"Drug and Alcohol Dependence"},{"issue":"6","key":"10.1016\/j.josat.2023.209164_bb0075","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/ADM.0000000000000981","article-title":"Shifting medication treatment practices in the COVID-19 pandemic: A statewide survey of Pennsylvania opioid treatment programs","volume":"16","author":"Krawczyk","year":"2022","journal-title":"Journal of Addiction Medicine"},{"issue":"1","key":"10.1016\/j.josat.2023.209164_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13722-021-00281-3","article-title":"Rural opioid treatment program patient perspectives on take-home methadone policy changes during COVID-19: A qualitative thematic analysis","volume":"16","author":"Levander","year":"2021","journal-title":"Addiction Science & Clinical Practice"},{"issue":"1","key":"10.1016\/j.josat.2023.209164_bb0085","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1080\/08897077.2021.1986768","article-title":"COVID-19-related policy changes for methadone take-home dosing: A multistate survey of opioid treatment program leadership","volume":"43","author":"Levander","year":"2022","journal-title":"Substance Abuse"},{"key":"10.1016\/j.josat.2023.209164_bb0090","author":"Markey"},{"key":"10.1016\/j.josat.2023.209164_bb0095","series-title":"As drug deaths soar, experts urge expanded access to Methadone","author":"Ovalle","year":"2023"},{"key":"10.1016\/j.josat.2023.209164_bb0100","author":"Pennsylvania General Assembly, Medical Marijuana Act"},{"key":"10.1016\/j.josat.2023.209164_bb0105","series-title":"R: A language and environment for statistical computing","author":"R Core Team","year":"2020"},{"issue":"12","key":"10.1016\/j.josat.2023.209164_bb0110","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1111\/add.13479","article-title":"Adopting the \u2018cascade of care\u2019framework: An opportunity to close the implementation gap in addiction care?","volume":"111","author":"Soc\u00edas","year":"2016","journal-title":"Addiction (Abingdon, England)"},{"key":"10.1016\/j.josat.2023.209164_bb0115","author":"Substance Abuse and Mental Health Services Administration"},{"key":"10.1016\/j.josat.2023.209164_bb0120","author":"Take-home privileges, Pa. Code \u00a7 715.16"},{"key":"10.1016\/j.josat.2023.209164_bb0125","author":"Test directory, Quest Diagnostics\u00ae"},{"key":"10.1016\/j.josat.2023.209164_bb0130","series-title":"Pub. L. No. 91\u2013513,84, 1236 Stat","author":"The Comprehensive Drug Abuse Prevention and Control Act","year":"1970"},{"key":"10.1016\/j.josat.2023.209164_bb0135","author":"The Narcotic Addicts Treatment Act of 1974"},{"key":"10.1016\/j.josat.2023.209164_bb0140","author":"Title 42 of the Code of Federal Regulations, Part 8"},{"issue":"3","key":"10.1016\/j.josat.2023.209164_bb0145","first-page":"6","article-title":"The \u201cregulatory fog\u201d of opioid treatment","volume":"22","author":"Wickersham","year":"2016","journal-title":"Journal of Public Management & Social Policy"},{"issue":"3","key":"10.1016\/j.josat.2023.209164_bb0150","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0376-8716(98)00097-0","article-title":"One-year mortality rates following methadone treatment discharge","volume":"52","author":"Zanis","year":"1998","journal-title":"Drug and Alcohol Dependence"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875923002151?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875923002151?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T15:50:52Z","timestamp":1757433052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875923002151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":30,"alternative-id":["S2949875923002151"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2023.209164","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19-related flexibility in methadone take-home doses associated with decreased attrition: Report from an opioid treatment program in central Pennsylvania","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2023.209164","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"209164"}}